State Street Corp Acquires New Stake in Ardent Health Partners, LLC (NYSE:ARDT)

State Street Corp acquired a new position in shares of Ardent Health Partners, LLC (NYSE:ARDT - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 107,560 shares of the company's stock, valued at approximately $1,977,000. State Street Corp owned 0.08% of Ardent Health Partners as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. BNP Paribas Financial Markets acquired a new stake in Ardent Health Partners in the 3rd quarter valued at $42,000. Financial Management Professionals Inc. bought a new position in Ardent Health Partners in the 3rd quarter valued at about $50,000. MetLife Investment Management LLC bought a new stake in Ardent Health Partners during the 3rd quarter worth approximately $135,000. Quadrature Capital Ltd purchased a new stake in shares of Ardent Health Partners in the third quarter worth approximately $229,000. Finally, Centiva Capital LP purchased a new position in shares of Ardent Health Partners during the third quarter valued at approximately $469,000.

Wall Street Analysts Forecast Growth

ARDT has been the topic of several recent analyst reports. Leerink Partners lifted their target price on shares of Ardent Health Partners from $23.00 to $25.00 and gave the stock an "outperform" rating in a research report on Tuesday, November 12th. Stephens reiterated an "overweight" rating and set a $24.00 price target on shares of Ardent Health Partners in a report on Thursday, September 19th. Royal Bank of Canada restated an "outperform" rating and issued a $23.00 price objective on shares of Ardent Health Partners in a research note on Thursday, November 14th. Bank of America lowered Ardent Health Partners from a "buy" rating to a "neutral" rating and decreased their target price for the company from $22.00 to $19.00 in a research report on Wednesday, November 6th. Finally, KeyCorp began coverage on shares of Ardent Health Partners in a report on Friday, October 11th. They issued an "overweight" rating and a $24.00 price target on the stock. Two equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, Ardent Health Partners has a consensus rating of "Buy" and an average price target of $22.00.

Ardent Health Partners Stock Performance

Shares of NYSE ARDT traded down $0.23 during midday trading on Thursday, hitting $16.85. The company's stock had a trading volume of 291,046 shares, compared to its average volume of 339,814. The company has a quick ratio of 1.78, a current ratio of 1.91 and a debt-to-equity ratio of 0.78. The company's fifty day simple moving average is $16.77. Ardent Health Partners, LLC has a one year low of $14.57 and a one year high of $20.72.

Ardent Health Partners Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.